Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Genetic and Environmental Factors Influence APOBEC Mutagenesis in Tumors

Challenge

High rates of APOBEC-signature mutations (generated by APOBEC3 enzymes) are found in many tumors, but factors affecting this mutation pattern are not well understood.

Advance

Ludmila Prokunina-Olsson, Ph.D., and collaborators found that two common germline variants in the APOBEC3 region on chromosome 22, previously associated with risk for bladder and breast cancer, were also associated with increased expression of mRNA transcripts that encode the APOBEC3B and APOBEC3A enzymes in bladder and breast tumors in The Cancer Genome Atlas (TCGA). Furthermore, the same germline variants and mRNA transcripts were significantly associated with increased number of APOBEC-signature mutations in these tumors. When the investigators exposed cancer cell lines to a viral infection or a DNA-damaging drug, they observed a strongly induced expression of APOBEC3A and APOBEC3B.

Impact

These findings suggest a tissue-specific role of environmental triggers for APOBEC mutagenesis that may lead to cancer, particularly in individuals with germline APOBEC3 risk variants.

Middlebrooks CD, Banday AR, Matsuda K, et al. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nature Genetics 2016

Email